Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone for OSA in Insomnic Stroke Patients
NCT04162743Phase 4Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trazodone hydrochloride prolonged-release tablets in obstructive sleep apnea (OSA), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Nocturnal Oxygen Saturation and Sleep Apnea Severity Index. Started Feb 2019; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04162743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04162743.